| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.977 | 0.001 | 0.977 | Neurokinin 1 antagonist | 0.368 0.003 CID_135985157 0.688 0.002 CID_154699529 0.184 0.004 CID_121616 0.953 0.001 CID_10113945 | ||
| 0.975 | 0.001 | 0.975 | Neurokinin antagonist | 0.338 0.004 CID_135985157 0.707 0.002 CID_154699529 0.167 0.005 CID_121616 0.942 0.002 CID_10113945 | ||
| 0.929 | 0.001 | 0.929 | Substance P antagonist | 0.507 0.003 CID_135985157 0.769 0.002 CID_154699529 0.127 0.005 CID_121616 0.882 0.001 CID_10113945 | ||
| 0.932 | 0.004 | 0.932 | Analgesic | 0.81 0.005 CID_154699529 0.419 0.076 CID_121616 0.888 0.005 CID_10113945 | ||
| 0.793 | 0.016 | 0.793 | Antiinflammatory | 0.79 0.017 CID_154699529 0.28 0.234 CID_121616 0.7 0.031 CID_10113945 | ||
| 0.579 | 0.004 | 0.579 | Antipruritic | 0.13 0.123 CID_135985157 0.311 0.013 CID_154699529 0.188 0.057 CID_121616 0.249 0.025 CID_10113945 | ||
| 0.319 | 0.099 | 0.784 | Toll-Like receptor 7 agonist | 0.784 0.005 CID_135985157 | CID_135985157 | |
| 0.315 | 0.102 | 0.775 | Toll-Like receptor agonist | 0.775 0.005 CID_135985157 0.201 0.2 CID_154699529 | CID_135985157 | |
| 0.124 | 0.008 | 0.124 | Neurokinin 2 antagonist | 0.046 0.025 CID_121616 0.067 0.017 CID_10113945 | ||
| 0.112 | 0.009 | 0.229 | Bombesin 3 receptor antagonist | 0.229 0.001 CID_135985157 0.134 0.005 CID_154699529 | CID_135985157 | |
| 0.103 | 0.005 | 0.103 | Neurokinin 3 antagonist | 0.051 0.027 CID_154699529 0.081 0.009 CID_121616 0.069 0.013 CID_10113945 | ||
| 0.223 | 0.138 | 0.27 | Immunomodulator | 0.27 0.1 CID_154699529 | CID_154699529 | |
| 0.079 | 0.035 | 0.084 | Phosphodiesterase VIII inhibitor | 0.084 0.028 CID_154699529 | CID_154699529 | |
| 0.03 | 0.009 | 0.035 | Phosphodiesterase 9A inhibitor | 0.035 0.005 CID_154699529 | CID_154699529 | |
| 0.028 | 0.011 | 0.034 | Phosphodiesterase IX inhibitor | 0.034 0.006 CID_154699529 | CID_154699529 | |
| 0.037 | 0.038 | 0.503 | Macrophage elastase inhibitor | 0.503 0.003 CID_135985157 0.053 0.022 CID_154699529 | CID_135985157 | |
| 0.03 | 0.04 | 0.04 | Antibiotic Aminoglycoside-like | 0.038 0.023 CID_154699529 0.04 0.021 CID_10113945 | CID_10113945 | |
| 0.011 | 0.056 | 0.101 | Bombesin 3 receptor agonist | 0.101 0.003 CID_135985157 | CID_135985157 | |
| 0.007 | 0.053 | 0.011 | CD80 antagonist | 0.011 0.007 CID_121616 | CID_121616 | |
| 0.012 | 0.059 | 0.12 | Bombesin agonist | 0.12 0.004 CID_135985157 | CID_135985157 | |
| 0.017 | 0.071 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 CID_10113945 | CID_10113945 | |
| 0.057 | 0.121 | 0.445 | 5-Lipoxygenase inhibitor | 0.445 0.005 CID_135985157 0.082 0.079 CID_154699529 0.138 0.043 CID_121616 | CID_135985157 | |
| 0.015 | 0.087 | 0.128 | Kinesin antagonist | 0.128 0.005 CID_121616 | CID_121616 | |
| 0.015 | 0.087 | 0.128 | Kinesin-like protein 1 inhibitor | 0.128 0.005 CID_121616 | CID_121616 | |
| 0.018 | 0.091 | 0.052 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.052 0.03 CID_10113945 | CID_10113945 | |
| 0.068 | 0.148 | 0.094 | Interleukin 12 antagonist | 0.094 0.065 CID_10113945 | CID_10113945 | |
| 0.027 | 0.109 | 0.059 | Guanylate cyclase stimulant | 0.059 0.014 CID_135985157 | CID_135985157 | |
| 0.194 | 0.284 | 0.4 | Calcium channel L-type activator | 0.345 0.121 CID_121616 0.4 0.081 CID_10113945 | CID_10113945 | |
| 0.009 | 0.117 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 CID_121616 | CID_121616 | |
| 0.015 | 0.125 | 0.027 | Motilin receptor antagonist | 0.027 0.019 CID_10113945 | CID_10113945 | |
| 0.027 | 0.143 | 0.044 | CF transmembrane conductance regulator antagonist | 0.044 0.016 CID_121616 | CID_121616 | |
| 0.005 | 0.135 | 0.024 | Alpha 2a adrenoreceptor agonist | 0.024 0.007 CID_135985157 0.021 0.008 CID_121616 | CID_135985157 | |
| 0.129 | 0.263 | 0.167 | Peptidyltransferase inhibitor | 0.167 0.154 CID_10113945 | CID_10113945 | |
| 0.084 | 0.221 | 0.125 | Polo-like kinase-3 inhibitor | 0.125 0.117 CID_121616 | CID_121616 | |
| 0.075 | 0.23 | 0.181 | Farnesoid X receptor antagonist | 0.181 0.028 CID_121616 0.122 0.099 CID_10113945 | CID_121616 | |
| 0.021 | 0.18 | 0.057 | Bombesin antagonist | 0.057 0.021 CID_135985157 | CID_135985157 | |
| 0.071 | 0.232 | 0.162 | Cell wall synthesis inhibitor | 0.132 0.083 CID_135985157 0.162 0.055 CID_121616 0.118 0.102 CID_10113945 | CID_121616 | |
| 0.059 | 0.226 | 0.295 | Nav1.5 sodium channel blocker | 0.115 0.061 CID_121616 0.295 0.006 CID_10113945 | CID_10113945 | |
| 0.008 | 0.178 | 0.043 | Glutamate (mGluR2) agonist | 0.043 0.016 CID_121616 | CID_121616 | |
| 0.01 | 0.187 | 0.047 | Glutamate (mGluR group II) agonist | 0.047 0.017 CID_121616 | CID_121616 | |
| 0.03 | 0.209 | 0.088 | Pregnane X receptor antagonist | 0.067 0.018 CID_135985157 0.088 0.005 CID_121616 0.066 0.019 CID_10113945 | CID_121616 | |
| 0.041 | 0.227 | 0.127 | EphA2 antagonist | 0.127 0.048 CID_10113945 | CID_10113945 | |
| 0.009 | 0.209 | 0.114 | Factor VIIa inhibitor | 0.114 0.01 CID_135985157 | CID_135985157 | |
| 0.031 | 0.257 | 0.249 | Potassium channel large-conductance Ca-activated activator | 0.249 0.005 CID_121616 | CID_121616 | |
| 0.051 | 0.279 | 0.202 | EphB2 antagonist | 0.202 0.087 CID_121616 | CID_121616 | |
| 0.047 | 0.276 | 0.093 | Toll-Like receptor 4 antagonist | 0.093 0.083 CID_154699529 | CID_154699529 | |
| 0.151 | 0.385 | 0.411 | MAP kinase kinase 6 inhibitor | 0.411 0.052 CID_121616 | CID_121616 | |
| 0.041 | 0.276 | 0.178 | DNA directed RNA polymerase inhibitor | 0.178 0.017 CID_135985157 | CID_135985157 | |
| 0.027 | 0.263 | 0.091 | Histone deacetylase SIRT1 stimulant | 0.091 0.034 CID_121616 | CID_121616 | |
| 0.027 | 0.263 | 0.091 | Histone deacetylase stimulant | 0.091 0.034 CID_121616 | CID_121616 | |
| 0.008 | 0.25 | 0.118 | Phosphodiesterase 3B inhibitor | 0.118 0.008 CID_135985157 | CID_135985157 | |
| 0.031 | 0.288 | 0.167 | Exportin-1 inhibitor | 0.167 0.003 CID_121616 | CID_121616 | |
| 0.094 | 0.352 | 0.664 | 5 Hydroxytryptamine release stimulant | 0.601 0.014 CID_121616 0.664 0.009 CID_10113945 | CID_10113945 | |
| 0.026 | 0.292 | 0.278 | Ca(v)2.2 blocker | 0.278 0.007 CID_121616 | CID_121616 | |
| 0.026 | 0.298 | 0.092 | Potassium channel (Tandem pore domain) blocker | 0.092 0.014 CID_121616 0.074 0.051 CID_10113945 | CID_121616 | |
| 0.015 | 0.291 | 0.053 | Somatostatin 4 agonist | 0.053 0.014 CID_10113945 | CID_10113945 | |
| 0.023 | 0.302 | 0.101 | Phosphodiesterase 3A inhibitor | 0.101 0.031 CID_135985157 | CID_135985157 | |
| 0.009 | 0.289 | 0.058 | Purinergic P2Y14 antagonist | 0.058 0.005 CID_121616 | CID_121616 | |
| 0.015 | 0.297 | 0.274 | Check point kinase 1 inhibitor | 0.274 0.005 CID_135985157 | CID_135985157 | |
| 0.005 | 0.297 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.011 CID_121616 0.019 0.011 CID_10113945 | CID_121616 | |
| 0.004 | 0.3 | 0.028 | Leukotriene B4 receptor 1 antagonist | 0.028 0.02 CID_121616 | CID_121616 | |
| 0.026 | 0.324 | 0.184 | MAP kinase 9 inhibitor | 0.184 0.026 CID_135985157 | CID_135985157 | |
| 0.013 | 0.314 | 0.092 | Elastase inhibitor | 0.092 0.012 CID_121616 | CID_121616 | |
| 0.015 | 0.32 | 0.17 | Phosphodiesterase III inhibitor | 0.17 0.008 CID_135985157 | CID_135985157 | |
| 0.008 | 0.315 | 0.044 | Peroxisome proliferator-activated receptor delta antagonist | 0.044 0.012 CID_121616 | CID_121616 | |
| 0.041 | 0.356 | 0.082 | Transcription factor NF kappa B stimulant | 0.082 0.065 CID_154699529 | CID_154699529 | |
| 0.004 | 0.323 | 0.112 | TRPM8 blocker | 0.112 0.005 CID_121616 | CID_121616 | |
| 0.027 | 0.358 | 0.237 | Sodium channel (voltage-gated) blocker | 0.137 0.065 CID_121616 0.237 0.018 CID_10113945 | CID_10113945 | |
| 0.019 | 0.352 | 0.104 | Transcription factor AP-1 inhibitor | 0.104 0.012 CID_121616 | CID_121616 | |
| 0.016 | 0.359 | 0.137 | Nav1.8 sodium channel blocker | 0.137 0.016 CID_121616 | CID_121616 | |
| 0.012 | 0.359 | 0.298 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.298 0.007 CID_135985157 | CID_135985157 | |
| 0.022 | 0.38 | 0.055 | Ca(v)3.2 blocker | 0.055 0.051 CID_121616 | CID_121616 | |
| 0.04 | 0.4 | 0.352 | Hypolipemic | 0.352 0.035 CID_121616 | CID_121616 | |
| 0.011 | 0.377 | 0.083 | MAP kinase 10 inhibitor | 0.083 0.048 CID_135985157 | CID_135985157 | |
| 0.01 | 0.376 | 0.045 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 CID_121616 | CID_121616 | |
| 0.006 | 0.376 | 0.04 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.013 CID_121616 | CID_121616 | |
| 0.005 | 0.375 | 0.04 | Progesterone receptor B antagonist | 0.04 0.004 CID_121616 | CID_121616 | |
| 0.001 | 0.373 | 0.017 | Lysophosphatidic acid receptor 3 agonist | 0.017 0.007 CID_121616 | CID_121616 | |
| 0.003 | 0.378 | 0.03 | Microsomal triglyceride transfer protein inhibitor | 0.03 0.005 CID_121616 | CID_121616 | |
| 0.004 | 0.381 | 0.046 | Glycine transporter 1 inhibitor | 0.046 0.017 CID_121616 | CID_121616 | |
| 0.03 | 0.414 | 0.089 | Heme oxygenase stimulant | 0.089 0.01 CID_121616 | CID_121616 | |
| 0.084 | 0.488 | 0.247 | Caspase 3 stimulant | 0.247 0.115 CID_121616 | CID_121616 | |
| 0.007 | 0.416 | 0.03 | Thymidine phosphorylase inhibitor | 0.03 0.012 CID_135985157 | CID_135985157 | |
| 0.09 | 0.502 | 0.257 | Cyclophilin D inhibitor | 0.257 0.205 CID_121616 | CID_121616 | |
| 0.009 | 0.424 | 0.04 | 5 Hydroxytryptamine 2B agonist | 0.04 0.025 CID_121616 0.036 0.035 CID_10113945 | CID_121616 | |
| 0.01 | 0.433 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.043 CID_10113945 | CID_10113945 | |
| 0.009 | 0.433 | 0.059 | GABA B receptor antagonist | 0.051 0.018 CID_135985157 0.059 0.013 CID_121616 | CID_121616 | |
| 0.006 | 0.432 | 0.035 | Nicotinic receptor beta4 subunit antagonist | 0.035 0.029 CID_121616 | CID_121616 | |
| 0.011 | 0.441 | 0.177 | Vanilloid 1 antagonist | 0.177 0.011 CID_121616 | CID_121616 | |
| 0.007 | 0.439 | 0.039 | Estrogen-related receptor alpha antagonist | 0.039 0.018 CID_121616 | CID_121616 | |
| 0.027 | 0.46 | 0.23 | Potassium channel (Voltage-sensitive) blocker | 0.23 0.077 CID_121616 | CID_121616 | |
| 0.128 | 0.565 | 0.531 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.512 0.028 CID_135985157 0.531 0.021 CID_121616 | CID_121616 | |
| 0.037 | 0.476 | 0.145 | Hemostatic | 0.145 0.075 CID_135985157 | CID_135985157 | |
| 0.109 | 0.55 | 0.211 | MAP kinase kinase 3 inhibitor | 0.211 0.093 CID_121616 | CID_121616 | |
| 0.005 | 0.448 | 0.068 | Cholesterol ester transfer protein antagonist | 0.068 0.004 CID_121616 | CID_121616 | |
| 0.004 | 0.452 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 CID_121616 | CID_121616 | |
| 0.006 | 0.454 | 0.162 | TRPA1 antagonist | 0.162 0.008 CID_121616 | CID_121616 | |
| 0.039 | 0.49 | 0.18 | Interleukin 6 antagonist | 0.18 0.054 CID_121616 | CID_121616 | |
| 0.005 | 0.456 | 0.032 | Nicotinic acid receptor 2 agonist | 0.032 0.031 CID_135985157 | CID_135985157 | |
| 0.061 | 0.514 | 0.225 | Growth factor agonist | 0.225 0.044 CID_121616 | CID_121616 | |
| 0.036 | 0.49 | 0.129 | Nitric oxide antagonist | 0.129 0.121 CID_121616 | CID_121616 | |
| 0.007 | 0.461 | 0.13 | Nav1.7 sodium channel blocker | 0.067 0.048 CID_121616 0.13 0.014 CID_10113945 | CID_10113945 | |
| 0.003 | 0.457 | 0.055 | Glutamate (mGluR2) antagonist | 0.055 0.007 CID_121616 | CID_121616 | |
| 0.027 | 0.483 | 0.078 | mTOR complex 2 inhibitor | 0.078 0.073 CID_121616 | CID_121616 | |
| 0.03 | 0.492 | 0.092 | Nav1.1 sodium channel blocker | 0.092 0.076 CID_121616 | CID_121616 | |
| 0.008 | 0.471 | 0.022 | Granulocyte colony stimulating factor receptor agonist | 0.022 0.005 CID_135985157 0.018 0.016 CID_121616 | CID_135985157 | |
| 0.011 | 0.474 | 0.054 | Adrenaline uptake inhibitor | 0.054 0.052 CID_10113945 | CID_10113945 | |
| 0.017 | 0.484 | 0.184 | Sodium channel blocker | 0.127 0.077 CID_121616 0.184 0.039 CID_10113945 | CID_10113945 | |
| 0.082 | 0.557 | 0.275 | Nitric-oxide synthase stimulant | 0.166 0.164 CID_135985157 0.275 0.019 CID_121616 0.214 0.067 CID_10113945 | CID_121616 | |
| 0.04 | 0.515 | 0.139 | Glutamate release inhibitor | 0.139 0.013 CID_121616 0.095 0.051 CID_10113945 | CID_121616 | |
| 0.023 | 0.501 | 0.151 | Anticoagulant | 0.151 0.079 CID_135985157 | CID_135985157 | |
| 0.021 | 0.5 | 0.173 | Cyclooxygenase inhibitor | 0.129 0.089 CID_135985157 0.173 0.055 CID_121616 | CID_121616 | |
| 0.006 | 0.486 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.035 CID_121616 | CID_121616 | |
| 0.016 | 0.504 | 0.177 | Cyclooxygenase 1 inhibitor | 0.166 0.049 CID_135985157 0.177 0.045 CID_121616 | CID_121616 | |
| 0.014 | 0.511 | 0.141 | Calcium channel L-type blocker | 0.141 0.011 CID_121616 | CID_121616 | |
| 0.007 | 0.506 | 0.049 | Mineralocorticoid receptor antagonist | 0.049 0.032 CID_121616 | CID_121616 | |
| 0.004 | 0.503 | 0.051 | Alpha 1d adrenoreceptor agonist | 0.051 0.016 CID_135985157 0.044 0.021 CID_121616 | CID_135985157 | |
| 0.003 | 0.507 | 0.07 | Glutamate (mGluR group II) antagonist | 0.07 0.009 CID_121616 | CID_121616 | |
| 0.03 | 0.539 | 0.117 | ABCA1 expression enhancer | 0.117 0.033 CID_121616 | CID_121616 | |
| 0.003 | 0.515 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.055 0.033 CID_10113945 | CID_10113945 | |
| 0.004 | 0.516 | 0.057 | Delayed rectifier potassium channel activator | 0.057 0.012 CID_121616 | CID_121616 | |
| 0.004 | 0.516 | 0.057 | Potassium channel KCNQ activator | 0.057 0.012 CID_121616 | CID_121616 | |
| 0.011 | 0.524 | 0.119 | MAP kinase 8 inhibitor | 0.119 0.044 CID_135985157 | CID_135985157 | |
| 0.005 | 0.518 | 0.1 | Peroxisome proliferator-activated receptor gamma agonist | 0.1 0.028 CID_121616 | CID_121616 | |
| 0.04 | 0.553 | 0.115 | DNA repair enzyme inhibitor | 0.115 0.082 CID_121616 | CID_121616 | |
| 0.006 | 0.521 | 0.204 | Cyclin-dependent kinase 5 inhibitor | 0.204 0.022 CID_135985157 | CID_135985157 | |
| 0.012 | 0.526 | 0.073 | Orexin receptor 1 antagonist | 0.073 0.048 CID_121616 | CID_121616 | |
| 0.021 | 0.54 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 CID_121616 | CID_121616 | |
| 0.04 | 0.564 | 0.253 | Immunosuppressant | 0.253 0.145 CID_10113945 | CID_10113945 | |
| 0.007 | 0.533 | 0.085 | TIE antagonist | 0.085 0.054 CID_121616 | CID_121616 | |
| 0.018 | 0.545 | 0.13 | Glycine receptor agonist | 0.13 0.01 CID_121616 | CID_121616 | |
| 0.07 | 0.599 | 0.214 | Ca2+-transporting ATPase inhibitor | 0.132 0.11 CID_135985157 0.214 0.003 CID_121616 0.13 0.118 CID_10113945 | CID_121616 | |
| 0.005 | 0.535 | 0.126 | Protein kinase (CK1) delta inhibitor | 0.126 0.069 CID_154699529 | CID_154699529 | |
| 0.008 | 0.539 | 0.108 | Lipase inhibitor | 0.108 0.023 CID_121616 | CID_121616 | |
| 0.005 | 0.538 | 0.1 | Acetylcholine M5 receptor agonist | 0.1 0.02 CID_121616 | CID_121616 | |
| 0.007 | 0.54 | 0.081 | TIE-2 antagonist | 0.081 0.057 CID_121616 | CID_121616 | |
| 0.002 | 0.538 | 0.012 | Calcium-dependent phospholipase A2 inhibitor | 0.012 0.008 CID_121616 | CID_121616 | |
| 0.023 | 0.56 | 0.169 | Amylase inhibitor | 0.169 0.055 CID_135985157 | CID_135985157 | |
| 0.004 | 0.545 | 0.039 | AMPA receptor agonist | 0.039 0.019 CID_121616 | CID_121616 | |
| 0.005 | 0.548 | 0.085 | Androgen agonist | 0.085 0.021 CID_121616 | CID_121616 | |
| 0.017 | 0.562 | 0.358 | Anticonvulsant | 0.358 0.028 CID_121616 | CID_121616 | |
| 0.011 | 0.557 | 0.037 | Aggrecanase 1 inhibitor | 0.037 0.033 CID_121616 | CID_121616 | |
| 0.016 | 0.564 | 0.132 | AMP-activated protein kinase stimulant | 0.132 0.04 CID_121616 | CID_121616 | |
| 0.009 | 0.566 | 0.084 | Stem cell growth factor agonist | 0.084 0.061 CID_121616 | CID_121616 | |
| 0.006 | 0.563 | 0.072 | Cannabinoid CB1 receptor antagonist | 0.072 0.033 CID_121616 | CID_121616 | |
| 0.004 | 0.565 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.014 CID_121616 | CID_121616 | |
| 0.005 | 0.566 | 0.132 | Monophenol monooxygenase inhibitor | 0.132 0.055 CID_121616 | CID_121616 | |
| 0.004 | 0.565 | 0.043 | CXC chemokine 3 receptor antagonist | 0.043 0.012 CID_121616 | CID_121616 | |
| 0.037 | 0.598 | 0.206 | Antiobesity | 0.206 0.201 CID_121616 | CID_121616 | |
| 0.069 | 0.633 | 0.151 | MAP kinase kinase 5 inhibitor | 0.151 0.147 CID_121616 | CID_121616 | |
| 0.005 | 0.569 | 0.115 | Epoxide hydrolase inhibitor | 0.115 0.018 CID_121616 | CID_121616 | |
| 0.038 | 0.607 | 0.266 | Antibacterial | 0.231 0.195 CID_121616 0.266 0.162 CID_10113945 | CID_10113945 | |
| 0.015 | 0.585 | 0.094 | Factor XII inhibitor | 0.094 0.044 CID_135985157 | CID_135985157 | |
| 0.05 | 0.621 | 0.183 | Lipocortins synthesis antagonist | 0.183 0.068 CID_121616 | CID_121616 | |
| 0.032 | 0.604 | 0.213 | Angiogenesis inhibitor | 0.213 0.155 CID_135985157 | CID_135985157 | |
| 0.012 | 0.585 | 0.144 | Cyclooxygenase 2 inhibitor | 0.144 0.058 CID_121616 | CID_121616 | |
| 0.013 | 0.589 | 0.174 | Creatine kinase inhibitor | 0.174 0.016 CID_121616 | CID_121616 | |
| 0.018 | 0.597 | 0.114 | Bile acid receptor antagonist | 0.114 0.026 CID_121616 | CID_121616 | |
| 0.023 | 0.603 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 CID_121616 | CID_121616 | |
| 0.002 | 0.586 | 0.03 | Glucagon receptor antagonist | 0.03 0.02 CID_121616 | CID_121616 | |
| 0.007 | 0.592 | 0.091 | Sphingosine 1-phosphate receptor 3 antagonist | 0.091 0.011 CID_121616 | CID_121616 | |
| 0.007 | 0.594 | 0.1 | Adenylate cyclase 1 inhibitor | 0.1 0.004 CID_121616 | CID_121616 | |
| 0.002 | 0.589 | 0.027 | Glutamate (mGluR1a) agonist | 0.027 0.01 CID_121616 | CID_121616 | |
| 0.015 | 0.604 | 0.242 | Potassium channel blocker | 0.242 0.07 CID_121616 | CID_121616 | |
| 0.048 | 0.639 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.094 CID_121616 | CID_121616 | |
| 0.004 | 0.595 | 0.058 | Leukotriene B4 antagonist | 0.058 0.03 CID_121616 | CID_121616 | |
| 0.008 | 0.6 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.046 CID_121616 | CID_121616 | |
| 0.019 | 0.618 | 0.255 | Lipoxygenase inhibitor | 0.255 0.097 CID_135985157 0.25 0.1 CID_121616 | CID_135985157 | |
| 0.003 | 0.603 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.037 0.006 CID_135985157 0.026 0.02 CID_121616 | CID_135985157 | |
| 0.005 | 0.606 | 0.068 | Liver X receptor agonist | 0.068 0.014 CID_121616 | CID_121616 | |
| 0.012 | 0.613 | 0.141 | Beta amyloid protein antagonist | 0.14 0.048 CID_121616 0.141 0.047 CID_10113945 | CID_10113945 | |
| 0.002 | 0.606 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 CID_121616 | CID_121616 | |
| 0.009 | 0.616 | 0.141 | Bcr-Abl kinase inhibitor | 0.141 0.019 CID_121616 | CID_121616 | |
| 0.005 | 0.612 | 0.044 | Liver X receptor alpha antagonist | 0.044 0.007 CID_121616 | CID_121616 | |
| 0.003 | 0.612 | 0.02 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 CID_121616 | CID_121616 | |
| 0.018 | 0.63 | 0.135 | Adenylate cyclase inhibitor | 0.135 0.056 CID_121616 | CID_121616 | |
| 0.023 | 0.635 | 0.277 | NADPH oxidase inhibitor | 0.277 0.016 CID_121616 | CID_121616 | |
| 0.003 | 0.615 | 0.102 | Glycine transporter inhibitor | 0.102 0.011 CID_121616 | CID_121616 | |
| 0.004 | 0.617 | 0.076 | 5 Hydroxytryptamine 2A agonist | 0.076 0.031 CID_121616 | CID_121616 | |
| 0.003 | 0.616 | 0.056 | CC chemokine 3 receptor antagonist | 0.056 0.021 CID_121616 | CID_121616 | |
| 0.003 | 0.618 | 0.046 | Prostaglandin F2 alpha agonist | 0.046 0.005 CID_121616 | CID_121616 | |
| 0.005 | 0.623 | 0.049 | Liver X receptor antagonist | 0.049 0.01 CID_121616 | CID_121616 | |
| 0.007 | 0.626 | 0.097 | Potassium channel (ATP-sensitive) activator | 0.097 0.004 CID_121616 | CID_121616 | |
| 0.012 | 0.632 | 0.14 | 5 Hydroxytryptamine 3A agonist | 0.14 0.041 CID_135985157 0.092 0.087 CID_121616 | CID_135985157 | |
| 0.006 | 0.626 | 0.083 | CC chemokine receptor antagonist | 0.083 0.049 CID_121616 | CID_121616 | |
| 0.027 | 0.649 | 0.111 | Interleukin 2 antagonist | 0.111 0.062 CID_121616 | CID_121616 | |
| 0.007 | 0.631 | 0.1 | Potassium channel (Inward rectifier) activator | 0.1 0.005 CID_121616 | CID_121616 | |
| 0.014 | 0.639 | 0.287 | Alpha-N-acetylglucosaminidase inhibitor | 0.241 0.024 CID_135985157 0.287 0.018 CID_121616 | CID_121616 | |
| 0.002 | 0.628 | 0.064 | Urate transporter 1 inhibitor | 0.064 0.013 CID_121616 | CID_121616 | |
| 0.016 | 0.642 | 0.156 | Cyclin-dependent kinase 8 inhibitor | 0.156 0.074 CID_121616 | CID_121616 | |
| 0.005 | 0.633 | 0.068 | Cholesterol esterase inhibitor | 0.068 0.012 CID_121616 | CID_121616 | |
| 0.006 | 0.634 | 0.059 | Protein kinase C theta inhibitor | 0.059 0.039 CID_135985157 | CID_135985157 | |
| 0.004 | 0.635 | 0.067 | Cannabinoid receptor antagonist | 0.067 0.053 CID_121616 | CID_121616 | |
| 0.003 | 0.637 | 0.059 | Angiotensin AT1 receptor antagonist | 0.059 0.007 CID_135985157 | CID_135985157 | |
| 0.005 | 0.64 | 0.056 | Dopamine uptake inhibitor | 0.056 0.042 CID_121616 | CID_121616 | |
| 0.008 | 0.644 | 0.187 | Potassium channel intermediate-conductance Ca-activated blocker | 0.187 0.004 CID_121616 | CID_121616 | |
| 0.008 | 0.645 | 0.145 | Potassium channel Kv1.1 blocker | 0.145 0.003 CID_121616 | CID_121616 | |
| 0.004 | 0.643 | 0.04 | Catechol O-methyltransferase inhibitor | 0.04 0.014 CID_121616 | CID_121616 | |
| 0.004 | 0.647 | 0.048 | Angiotensin II receptor antagonist | 0.048 0.008 CID_135985157 | CID_135985157 | |
| 0.012 | 0.658 | 0.245 | Potassium channel (Ca-activated) activator | 0.245 0.008 CID_121616 | CID_121616 | |
| 0.012 | 0.658 | 0.125 | Beta glucuronidase inhibitor | 0.095 0.078 CID_135985157 0.125 0.041 CID_121616 | CID_121616 | |
| 0.013 | 0.66 | 0.145 | Calcium channel (voltage-sensitive) blocker | 0.145 0.036 CID_121616 | CID_121616 | |
| 0.006 | 0.653 | 0.077 | Secretase beta inhibitor | 0.077 0.039 CID_121616 | CID_121616 | |
| 0.033 | 0.681 | 0.174 | Hypoglycemic | 0.174 0.141 CID_121616 | CID_121616 | |
| 0.008 | 0.656 | 0.123 | Urease inhibitor | 0.123 0.042 CID_121616 | CID_121616 | |
| 0 | 0.65 | 0.029 | Progesterone receptor A antagonist | 0.029 0.003 CID_121616 | CID_121616 | |
| 0.005 | 0.655 | 0.061 | Collagenase 3 inhibitor | 0.061 0.04 CID_135985157 | CID_135985157 | |
| 0.009 | 0.659 | 0.056 | Fatty acid synthase inhibitor | 0.056 0.041 CID_135985157 | CID_135985157 | |
| 0.028 | 0.679 | 0.089 | Ca(v)3.1 blocker | 0.089 0.038 CID_121616 | CID_121616 | |
| 0.01 | 0.663 | 0.081 | Myeloperoxidase inhibitor | 0.081 0.066 CID_121616 | CID_121616 | |
| 0.013 | 0.668 | 0.164 | Calcium channel blocker | 0.164 0.048 CID_121616 | CID_121616 | |
| 0.023 | 0.678 | 0.173 | ATPase inhibitor | 0.173 0.067 CID_121616 | CID_121616 | |
| 0.005 | 0.661 | 0.199 | HIV-1 reverse transcriptase inhibitor | 0.199 0.01 CID_135985157 | CID_135985157 | |
| 0.01 | 0.668 | 0.066 | Potassium channel (Ca-activated) blocker | 0.066 0.032 CID_121616 | CID_121616 | |
| 0.005 | 0.664 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_121616 | CID_121616 | |
| 0.002 | 0.662 | 0.07 | Peroxisome proliferator-activated receptor alpha agonist | 0.07 0.022 CID_121616 | CID_121616 | |
| 0.006 | 0.667 | 0.148 | Potassium channel (Voltage-sensitive) activator | 0.148 0.014 CID_121616 | CID_121616 | |
| 0.004 | 0.667 | 0.055 | Fibroblast growth factor 4 antagonist | 0.055 0.044 CID_135985157 | CID_135985157 | |
| 0.003 | 0.666 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 CID_121616 | CID_121616 | |
| 0.003 | 0.667 | 0.211 | MAO B inhibitor | 0.211 0.023 CID_121616 | CID_121616 | |
| 0.004 | 0.669 | 0.085 | Pim-3 kinase inhibitor | 0.085 0.067 CID_135985157 | CID_135985157 | |
| 0.011 | 0.681 | 0.138 | Dihydroorotate oxidase inhibitor | 0.068 0.019 CID_135985157 0.138 0.003 CID_121616 | CID_121616 | |
| 0.002 | 0.672 | 0.043 | 5-Alpha-reductase inhibitor | 0.043 0.022 CID_121616 | CID_121616 | |
| 0.006 | 0.677 | 0.088 | Expectorant | 0.088 0.084 CID_121616 | CID_121616 | |
| 0.018 | 0.689 | 0.17 | Cytokine production inhibitor | 0.17 0.049 CID_121616 | CID_121616 | |
| 0.004 | 0.675 | 0.142 | Glycine transporter 2 inhibitor | 0.142 0.008 CID_121616 | CID_121616 | |
| 0.006 | 0.679 | 0.148 | Alcohol dehydrogenase inhibitor | 0.097 0.056 CID_135985157 0.148 0.021 CID_121616 | CID_121616 | |
| 0.024 | 0.702 | 0.408 | Cholesterol antagonist | 0.408 0.048 CID_121616 | CID_121616 | |
| 0.002 | 0.682 | 0.034 | Kynurenine 3 monooxygenase inhibitor | 0.034 0.013 CID_121616 | CID_121616 | |
| 0.037 | 0.718 | 0.263 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.263 0.054 CID_135985157 | CID_135985157 | |
| 0.007 | 0.691 | 0.081 | Glycine receptor antagonist | 0.081 0.055 CID_121616 | CID_121616 | |
| 0.007 | 0.695 | 0.118 | Mucolytic | 0.118 0.056 CID_121616 | CID_121616 | |
| 0.03 | 0.718 | 0.124 | MAP kinase 3 inhibitor | 0.124 0.123 CID_121616 | CID_121616 | |
| 0.003 | 0.694 | 0.074 | Delayed rectifier potassium channel blocker | 0.074 0.005 CID_121616 | CID_121616 | |
| 0.008 | 0.7 | 0.179 | Sphingosine 1-phosphate receptor 2 antagonist | 0.179 0.016 CID_121616 | CID_121616 | |
| 0.001 | 0.694 | 0.023 | Peroxisome proliferator-activated receptor alpha antagonist | 0.023 0.014 CID_121616 | CID_121616 | |
| 0.014 | 0.708 | 0.126 | Triose-phosphate isomerase inhibitor | 0.091 0.058 CID_135985157 0.126 0.029 CID_121616 | CID_121616 | |
| 0.006 | 0.704 | 0.106 | Sphingosine 1-phosphate receptor antagonist | 0.106 0.018 CID_121616 | CID_121616 | |
| 0.005 | 0.703 | 0.084 | Chemokine receptor antagonist | 0.084 0.081 CID_121616 | CID_121616 | |
| 0.017 | 0.715 | 0.163 | Cyclic AMP phosphodiesterase inhibitor | 0.163 0.132 CID_135985157 | CID_135985157 | |
| 0.007 | 0.706 | 0.133 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.133 0.091 CID_135985157 | CID_135985157 | |
| 0.008 | 0.709 | 0.232 | Neurotrophic factor | 0.232 0.016 CID_121616 | CID_121616 | |
| 0.005 | 0.708 | 0.205 | Androgen antagonist | 0.205 0.013 CID_121616 | CID_121616 | |
| 0.002 | 0.706 | 0.07 | Peroxisome proliferator-activated receptor delta agonist | 0.07 0.009 CID_121616 | CID_121616 | |
| 0.007 | 0.712 | 0.156 | Alkaline phosphatase inhibitor | 0.156 0.056 CID_121616 | CID_121616 | |
| 0.004 | 0.71 | 0.078 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.078 0.021 CID_135985157 0.06 0.035 CID_121616 | CID_135985157 | |
| 0.003 | 0.711 | 0.043 | Leukotriene D4 antagonist | 0.043 0.011 CID_121616 | CID_121616 | |
| 0.008 | 0.716 | 0.214 | Ferrochelatase inhibitor | 0.163 0.033 CID_135985157 0.214 0.019 CID_121616 | CID_121616 | |
| 0.002 | 0.712 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 CID_121616 | CID_121616 | |
| 0.004 | 0.714 | 0.121 | Aryl hydrocarbon receptor antagonist | 0.121 0.008 CID_121616 | CID_121616 | |
| 0.009 | 0.72 | 0.227 | UDP-glucose 4-epimerase inhibitor | 0.159 0.026 CID_135985157 0.227 0.015 CID_121616 | CID_121616 | |
| 0.005 | 0.717 | 0.083 | Peroxisome proliferator-activated receptor gamma antagonist | 0.083 0.029 CID_121616 | CID_121616 | |
| 0.012 | 0.724 | 0.125 | Sphingomyelinase inhibitor | 0.125 0.038 CID_121616 | CID_121616 | |
| 0.022 | 0.734 | 0.152 | Adenylate kinase inhibitor | 0.147 0.028 CID_135985157 0.152 0.026 CID_121616 | CID_121616 | |
| 0.004 | 0.716 | 0.108 | Glutamate receptor agonist | 0.108 0.032 CID_121616 | CID_121616 | |
| 0.003 | 0.716 | 0.066 | Dihydroorotate dehydrogenase inhibitor | 0.066 0.024 CID_121616 | CID_121616 | |
| 0.01 | 0.723 | 0.181 | Nav1.6 sodium channel blocker | 0.181 0.027 CID_121616 0.114 0.106 CID_10113945 | CID_121616 | |
| 0.004 | 0.719 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.064 0.019 CID_121616 | CID_121616 | |
| 0.009 | 0.724 | 0.252 | Mannose-6-phosphate isomerase inhibitor | 0.16 0.056 CID_135985157 0.252 0.012 CID_121616 | CID_121616 | |
| 0.002 | 0.721 | 0.039 | Free fatty acid receptor 1 antagonist | 0.039 0.017 CID_121616 | CID_121616 | |
| 0.011 | 0.73 | 0.176 | Focal adhesion kinase 2 inhibitor | 0.176 0.093 CID_121616 | CID_121616 | |
| 0.006 | 0.726 | 0.121 | Calcium antagonist | 0.121 0.034 CID_121616 | CID_121616 | |
| 0.004 | 0.725 | 0.225 | MAO inhibitor | 0.225 0.034 CID_121616 | CID_121616 | |
| 0.008 | 0.729 | 0.102 | Mediator release inhibitor | 0.102 0.068 CID_121616 | CID_121616 | |
| 0.005 | 0.728 | 0.073 | Sphingosine 1-phosphate receptor 1 antagonist | 0.073 0.017 CID_121616 | CID_121616 | |
| 0.002 | 0.727 | 0.037 | Apolipoprotein B inhibitor | 0.037 0.006 CID_121616 | CID_121616 | |
| 0.006 | 0.732 | 0.071 | Protein kinase C beta inhibitor | 0.071 0.045 CID_135985157 | CID_135985157 | |
| 0.003 | 0.731 | 0.057 | Liver X receptor alpha agonist | 0.057 0.014 CID_121616 | CID_121616 | |
| 0.001 | 0.729 | 0.104 | Progesterone antagonist | 0.104 0.009 CID_121616 | CID_121616 | |
| 0.006 | 0.734 | 0.178 | Potassium channel activator | 0.178 0.012 CID_121616 | CID_121616 | |
| 0.004 | 0.732 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 CID_121616 | CID_121616 | |
| 0.003 | 0.732 | 0.074 | Na+ K+ transporting ATPase inhibitor | 0.074 0.056 CID_121616 | CID_121616 | |
| 0.015 | 0.744 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 CID_135985157 0.105 0.039 CID_121616 | CID_135985157 | |
| 0.002 | 0.732 | 0.038 | CDK5/p25 inhibitor | 0.038 0.033 CID_121616 | CID_121616 | |
| 0.003 | 0.733 | 0.074 | Leukotriene antagonist | 0.074 0.037 CID_121616 | CID_121616 | |
| 0.013 | 0.747 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.19 0.017 CID_121616 | CID_121616 | |
| 0.004 | 0.739 | 0.038 | Protein kinase (CK2) beta inhibitor | 0.038 0.014 CID_135985157 | CID_135985157 | |
| 0.012 | 0.747 | 0.174 | Protein kinase stimulant | 0.174 0.053 CID_121616 | CID_121616 | |
| 0.019 | 0.756 | 0.096 | Glutamate (mGluR7) agonist | 0.096 0.07 CID_121616 | CID_121616 | |
| 0.001 | 0.739 | 0.042 | Nicotinic alpha3beta4 receptor agonist | 0.042 0.009 CID_121616 | CID_121616 | |
| 0.004 | 0.742 | 0.031 | Estrogen-related receptor gamma antagonist | 0.031 0.014 CID_121616 | CID_121616 | |
| 0.002 | 0.741 | 0.041 | Guanylate cyclase inhibitor | 0.041 0.032 CID_121616 | CID_121616 | |
| 0.001 | 0.74 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.029 0.019 CID_135985157 | CID_135985157 | |
| 0.004 | 0.744 | 0.171 | Catalase inhibitor | 0.171 0.021 CID_121616 | CID_121616 | |
| 0.011 | 0.752 | 0.128 | Anabolic | 0.105 0.056 CID_135985157 0.128 0.032 CID_121616 | CID_121616 | |
| 0.003 | 0.743 | 0.06 | Neutrophil collagenase inhibitor | 0.06 0.051 CID_135985157 | CID_135985157 | |
| 0.002 | 0.744 | 0.089 | Potassium channel Kv1.3 blocker | 0.089 0.01 CID_121616 | CID_121616 | |
| 0.004 | 0.745 | 0.079 | CC chemokine 2 receptor antagonist | 0.079 0.02 CID_121616 | CID_121616 | |
| 0.002 | 0.745 | 0.048 | Liver X receptor beta agonist | 0.048 0.011 CID_121616 | CID_121616 | |
| 0.039 | 0.782 | 0.351 | Calcium channel activator | 0.351 0.049 CID_121616 | CID_121616 | |
| 0.005 | 0.749 | 0.03 | Vanilloid 4 antagonist | 0.03 0.029 CID_121616 | CID_121616 | |
| 0.018 | 0.762 | 0.428 | Neurotrophic factor enhancer | 0.428 0.005 CID_121616 | CID_121616 | |
| 0.02 | 0.764 | 0.054 | Lipocortins synthesis agonist | 0.054 0.053 CID_121616 | CID_121616 | |
| 0.026 | 0.77 | 0.508 | Histamine release inhibitor | 0.387 0.082 CID_135985157 0.508 0.026 CID_121616 | CID_121616 | |
| 0.006 | 0.75 | 0.039 | Adenosine uptake inhibitor | 0.039 0.014 CID_121616 | CID_121616 | |
| 0.031 | 0.776 | 0.642 | 5 Hydroxytryptamine release inhibitor | 0.329 0.134 CID_135985157 0.642 0.007 CID_121616 | CID_121616 | |
| 0.004 | 0.75 | 0.067 | Sphingosine kinase 2 inhibitor | 0.067 0.024 CID_121616 | CID_121616 | |
| 0.007 | 0.753 | 0.056 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.027 CID_135985157 0.056 0.022 CID_121616 | CID_121616 | |
| 0.011 | 0.759 | 0.119 | Nav1.2 sodium channel blocker | 0.119 0.085 CID_121616 | CID_121616 | |
| 0.007 | 0.755 | 0.132 | Ornithine decarboxylase inhibitor | 0.132 0.018 CID_121616 | CID_121616 | |
| 0.002 | 0.75 | 0.03 | Apolipoprotein B-100 inhibitor | 0.03 0.006 CID_121616 | CID_121616 | |
| 0.003 | 0.754 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.024 CID_135985157 0.031 0.025 CID_121616 | CID_135985157 | |
| 0.01 | 0.761 | 0.082 | MDM2 inhibitor | 0.082 0.018 CID_121616 | CID_121616 | |
| 0.005 | 0.756 | 0.095 | MAP kinase kinase 1 inhibitor | 0.095 0.064 CID_121616 | CID_121616 | |
| 0.007 | 0.762 | 0.252 | Alpha-glucosidase inhibitor | 0.252 0.186 CID_135985157 | CID_135985157 | |
| 0.003 | 0.76 | 0.061 | Dihydroorotase inhibitor | 0.061 0.016 CID_121616 | CID_121616 | |
| 0.012 | 0.77 | 0.179 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.073 CID_135985157 0.179 0.019 CID_121616 | CID_121616 | |
| 0.021 | 0.78 | 0.166 | CF transmembrane conductance regulator agonist | 0.142 0.091 CID_135985157 0.166 0.052 CID_121616 | CID_121616 | |
| 0.008 | 0.767 | 0.063 | 5 Hydroxytryptamine 3 agonist | 0.063 0.044 CID_135985157 | CID_135985157 | |
| 0.01 | 0.769 | 0.135 | Cathepsin H inhibitor | 0.115 0.083 CID_135985157 0.135 0.058 CID_121616 | CID_121616 | |
| 0.002 | 0.764 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.01 CID_121616 | CID_121616 | |
| 0.002 | 0.764 | 0.024 | Prostaglandin EP4 antagonist | 0.024 0.02 CID_121616 | CID_121616 | |
| 0 | 0.764 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 CID_121616 | CID_121616 | |
| 0.019 | 0.784 | 0.143 | Transcription factor STAT6 inhibitor | 0.143 0.029 CID_121616 | CID_121616 | |
| 0.004 | 0.769 | 0.09 | MAO A inhibitor | 0.09 0.071 CID_121616 | CID_121616 | |
| 0.003 | 0.768 | 0.045 | Nicotinic acid receptor agonist | 0.045 0.017 CID_135985157 | CID_135985157 | |
| 0.031 | 0.797 | 0.292 | Apoptosis antagonist | 0.292 0.091 CID_121616 | CID_121616 | |
| 0.003 | 0.769 | 0.131 | Glutamate decarboxylase inhibitor | 0.079 0.045 CID_135985157 0.131 0.017 CID_121616 | CID_121616 | |
| 0.002 | 0.77 | 0.047 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.047 0.011 CID_121616 | CID_121616 | |
| 0.007 | 0.776 | 0.152 | I kappa B kinase epsilon inhibitor | 0.152 0.117 CID_121616 | CID_121616 | |
| 0.005 | 0.774 | 0.138 | Macrophage migration inhibitory factor inhibitor | 0.138 0.019 CID_121616 | CID_121616 | |
| 0.004 | 0.775 | 0.139 | Psychostimulant | 0.139 0.126 CID_121616 | CID_121616 | |
| 0.033 | 0.803 | 0.494 | Caspase 9 stimulant | 0.324 0.169 CID_135985157 0.494 0.062 CID_121616 | CID_121616 | |
| 0.006 | 0.778 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.065 0.005 CID_121616 | CID_121616 | |
| 0.003 | 0.775 | 0.089 | Vanilloid antagonist | 0.089 0.041 CID_121616 | CID_121616 | |
| 0.013 | 0.786 | 0.184 | Melanin inhibitor | 0.184 0.049 CID_121616 | CID_121616 | |
| 0.017 | 0.79 | 0.322 | 3C-like protease (Human coronavirus) inhibitor | 0.177 0.068 CID_135985157 0.322 0.008 CID_121616 | CID_121616 | |
| 0.013 | 0.787 | 0.19 | HIV-1 integrase (Overall Integration) inhibitor | 0.19 0.014 CID_121616 | CID_121616 | |
| 0.002 | 0.777 | 0.141 | Phosphofructokinase-1 inhibitor | 0.141 0.02 CID_135985157 0.087 0.037 CID_121616 | CID_135985157 | |
| 0.005 | 0.78 | 0.129 | Lck kinase inhibitor | 0.129 0.078 CID_135985157 | CID_135985157 | |
| 0.005 | 0.781 | 0.093 | Polo-like kinase-1 inhibitor | 0.093 0.056 CID_121616 | CID_121616 | |
| 0.002 | 0.779 | 0.071 | Liver X receptor beta antagonist | 0.071 0.004 CID_121616 | CID_121616 | |
| 0.002 | 0.78 | 0.056 | Sphingosine 1-phosphate receptor agonist | 0.056 0.019 CID_121616 | CID_121616 | |
| 0.015 | 0.793 | 0.093 | Transcription factor RelA inhibitor | 0.093 0.009 CID_121616 | CID_121616 | |
| 0.006 | 0.785 | 0.14 | Calcium channel N-type blocker | 0.14 0.044 CID_121616 | CID_121616 | |
| 0.012 | 0.791 | 0.171 | P-glycoprotein inhibitor | 0.171 0.088 CID_121616 | CID_121616 | |
| 0.018 | 0.8 | 0.211 | Interferon gamma antagonist | 0.126 0.119 CID_135985157 0.211 0.037 CID_121616 | CID_121616 | |
| 0.013 | 0.796 | 0.116 | Nav1.3 sodium channel blocker | 0.116 0.079 CID_121616 | CID_121616 | |
| 0.006 | 0.789 | 0.123 | 5 Hydroxytryptamine 2B antagonist | 0.123 0.058 CID_121616 | CID_121616 | |
| 0.002 | 0.785 | 0.056 | Sphingosine 1-phosphate receptor 1 agonist | 0.056 0.015 CID_121616 | CID_121616 | |
| 0.015 | 0.799 | 0.173 | Photosensitizer | 0.173 0.02 CID_121616 | CID_121616 | |
| 0 | 0.786 | 0.022 | G-protein-coupled receptor 120 agonist | 0.022 0.008 CID_121616 | CID_121616 | |
| 0.006 | 0.792 | 0.128 | Cystathionine beta-synthase inhibitor | 0.097 0.081 CID_135985157 0.128 0.052 CID_121616 | CID_121616 | |
| 0.009 | 0.795 | 0.066 | Elastase 1 inhibitor | 0.066 0.053 CID_121616 | CID_121616 | |
| 0.006 | 0.792 | 0.166 | Cholesterol synthesis inhibitor | 0.166 0.037 CID_121616 | CID_121616 | |
| 0.003 | 0.791 | 0.117 | Nicotinic alpha4beta2 receptor antagonist | 0.117 0.019 CID_121616 | CID_121616 | |
| 0.019 | 0.809 | 0.272 | Gastrin inhibitor | 0.272 0.056 CID_121616 | CID_121616 | |
| 0.009 | 0.8 | 0.255 | DNA synthesis inhibitor | 0.255 0.063 CID_135985157 0.188 0.142 CID_121616 | CID_135985157 | |
| 0.009 | 0.799 | 0.104 | Glutathione S-transferase inhibitor | 0.104 0.034 CID_121616 | CID_121616 | |
| 0.007 | 0.799 | 0.099 | Purinergic P2X2 antagonist | 0.099 0.031 CID_135985157 | CID_135985157 | |
| 0.009 | 0.801 | 0.104 | Xanthine oxidase inhibitor | 0.104 0.057 CID_135985157 | CID_135985157 | |
| 0.035 | 0.828 | 0.293 | Tyrosine 3 hydroxylase inhibitor | 0.248 0.07 CID_135985157 0.293 0.036 CID_121616 | CID_121616 | |
| 0.003 | 0.796 | 0.026 | ICAM 1 antagonist | 0.026 0.01 CID_121616 | CID_121616 | |
| 0.003 | 0.796 | 0.105 | Amidase inhibitor | 0.105 0.022 CID_121616 | CID_121616 | |
| 0.004 | 0.798 | 0.105 | Glutamate (mGluR7) antagonist | 0.105 0.008 CID_121616 | CID_121616 | |
| 0.001 | 0.797 | 0.035 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.013 CID_121616 | CID_121616 | |
| 0.002 | 0.798 | 0.065 | NMDA receptor glycine site agonist | 0.065 0.04 CID_121616 | CID_121616 | |
| 0.003 | 0.801 | 0.082 | 5 Hydroxytryptamine 2C antagonist | 0.082 0.059 CID_121616 | CID_121616 | |
| 0.017 | 0.815 | 0.217 | Tumour necrosis factor antagonist | 0.217 0.044 CID_121616 | CID_121616 | |
| 0.009 | 0.808 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 CID_121616 | CID_121616 | |
| 0.007 | 0.807 | 0.2 | Non-steroidal antiinflammatory agent | 0.2 0.071 CID_121616 | CID_121616 | |
| 0.006 | 0.807 | 0.152 | Aldosterone antagonist | 0.152 0.005 CID_121616 | CID_121616 | |
| 0.004 | 0.805 | 0.1 | Anesthetic local | 0.1 0.082 CID_121616 | CID_121616 | |
| 0.002 | 0.803 | 0.054 | Histamine H1 receptor agonist | 0.054 0.013 CID_121616 | CID_121616 | |
| 0.016 | 0.818 | 0.272 | Vasodilator, peripheral | 0.272 0.112 CID_121616 | CID_121616 | |
| 0.009 | 0.81 | 0.167 | Purinergic P2X1 antagonist | 0.087 0.021 CID_135985157 0.167 0.005 CID_121616 | CID_121616 | |
| 0.017 | 0.819 | 0.242 | Vasodilator, coronary | 0.242 0.142 CID_121616 | CID_121616 | |
| 0.018 | 0.82 | 0.451 | Superoxide dismutase inhibitor | 0.222 0.096 CID_135985157 0.451 0.019 CID_121616 | CID_121616 | |
| 0.019 | 0.821 | 0.068 | Calcium channel P-type blocker | 0.068 0.031 CID_121616 | CID_121616 | |
| 0.002 | 0.805 | 0.046 | Thymidylate synthase inhibitor | 0.046 0.033 CID_135985157 | CID_135985157 | |
| 0.004 | 0.808 | 0.314 | Anesthetic general | 0.152 0.112 CID_135985157 0.314 0.03 CID_121616 | CID_121616 | |
| 0.004 | 0.81 | 0.054 | Glucosylceramidase inhibitor | 0.054 0.04 CID_121616 | CID_121616 | |
| 0.002 | 0.808 | 0.045 | Purinergic P2Y antagonist | 0.045 0.031 CID_121616 | CID_121616 | |
| 0.002 | 0.809 | 0.062 | Nerve growth factor antagonist | 0.062 0.008 CID_121616 | CID_121616 | |
| 0.006 | 0.813 | 0.095 | Protease 3C (Human rhinovirus) inhibitor | 0.095 0.018 CID_121616 | CID_121616 | |
| 0.045 | 0.853 | 0.388 | 5 Hydroxytryptamine uptake stimulant | 0.192 0.168 CID_135985157 0.388 0.016 CID_121616 | CID_121616 | |
| 0.006 | 0.817 | 0.047 | Heme oxygenase inhibitor | 0.047 0.017 CID_121616 | CID_121616 | |
| 0.006 | 0.817 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 CID_121616 | CID_121616 | |
| 0.003 | 0.815 | 0.151 | Sphingosine 1-phosphate receptor 4 agonist | 0.151 0.008 CID_121616 | CID_121616 | |
| 0.003 | 0.816 | 0.222 | Phospholipase A2 inhibitor | 0.222 0.032 CID_121616 | CID_121616 | |
| 0.002 | 0.818 | 0.167 | Prostaglandin-E synthase inhibitor | 0.167 0.009 CID_121616 | CID_121616 | |
| 0.004 | 0.82 | 0.146 | Cytidine deaminase inhibitor | 0.146 0.078 CID_121616 | CID_121616 | |
| 0.007 | 0.824 | 0.152 | Toll-Like receptor 2 antagonist | 0.152 0.051 CID_121616 | CID_121616 | |
| 0.003 | 0.821 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.05 CID_121616 | CID_121616 | |
| 0.003 | 0.821 | 0.062 | Prolyl endopeptidase inhibitor | 0.062 0.022 CID_121616 | CID_121616 | |
| 0.016 | 0.836 | 0.258 | RNA-directed DNA polymerase inhibitor | 0.201 0.098 CID_135985157 0.258 0.045 CID_121616 | CID_121616 | |
| 0.004 | 0.825 | 0.289 | Calpain 2 inhibitor | 0.289 0.121 CID_121616 | CID_121616 | |
| 0.005 | 0.827 | 0.043 | Adenosine deaminase inhibitor | 0.043 0.037 CID_121616 | CID_121616 | |
| 0.001 | 0.826 | 0.013 | Cyclin D2 inhibitor | 0.013 0.009 CID_121616 | CID_121616 | |
| 0.001 | 0.826 | 0.039 | Fumarate hydratase inhibitor | 0.039 0.019 CID_121616 | CID_121616 | |
| 0.003 | 0.831 | 0.343 | Aryl hydrocarbon receptor agonist | 0.172 0.119 CID_135985157 0.343 0.05 CID_121616 | CID_121616 | |
| 0.001 | 0.829 | 0.044 | Retinoid X receptor agonist | 0.044 0.02 CID_121616 | CID_121616 | |
| 0.002 | 0.83 | 0.05 | Leukotriene C4 antagonist | 0.05 0.011 CID_121616 | CID_121616 | |
| 0.007 | 0.834 | 0.153 | Pregnane X receptor agonist | 0.153 0.047 CID_121616 | CID_121616 | |
| 0.009 | 0.838 | 0.075 | Vanilloid 4 agonist | 0.075 0.051 CID_121616 | CID_121616 | |
| 0.004 | 0.837 | 0.123 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.123 0.007 CID_121616 | CID_121616 | |
| 0.047 | 0.881 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.181 0.103 CID_135985157 0.201 0.061 CID_121616 | CID_121616 | |
| 0.003 | 0.837 | 0.1 | Inducible nitric-oxide synthase inhibitor | 0.1 0.037 CID_121616 | CID_121616 | |
| 0.007 | 0.843 | 0.068 | Glutamate (mGluR6) antagonist | 0.068 0.044 CID_121616 | CID_121616 | |
| 0.022 | 0.858 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.044 CID_121616 | CID_121616 | |
| 0.002 | 0.839 | 0.089 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.025 CID_135985157 0.07 0.035 CID_121616 | CID_135985157 | |
| 0.005 | 0.843 | 0.158 | GABA C receptor antagonist | 0.113 0.06 CID_135985157 0.158 0.026 CID_121616 | CID_121616 | |
| 0.001 | 0.84 | 0.048 | AMPA receptor antagonist | 0.048 0.033 CID_135985157 | CID_135985157 | |
| 0.001 | 0.84 | 0.037 | Dopamine D5 agonist | 0.037 0.032 CID_121616 | CID_121616 | |
| 0.007 | 0.846 | 0.16 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.16 0.126 CID_121616 | CID_121616 | |
| 0.009 | 0.849 | 0.183 | Interleukin 1 antagonist | 0.183 0.041 CID_121616 | CID_121616 | |
| 0.003 | 0.843 | 0.074 | Leukotriene C antagonist | 0.074 0.011 CID_121616 | CID_121616 | |
| 0.004 | 0.844 | 0.026 | Glucosylceramidase stimulant | 0.026 0.025 CID_121616 | CID_121616 | |
| 0.016 | 0.856 | 0.105 | Estrogen-related receptor beta agonist | 0.105 0.019 CID_121616 | CID_121616 | |
| 0.003 | 0.844 | 0.059 | Epithelial sodium channel blocker | 0.059 0.031 CID_121616 | CID_121616 | |
| 0.004 | 0.848 | 0.053 | Glutamate (mGluR8) agonist | 0.053 0.01 CID_121616 | CID_121616 | |
| 0.002 | 0.846 | 0.043 | Histamine H2 receptor agonist | 0.043 0.03 CID_135985157 | CID_135985157 | |
| 0.005 | 0.849 | 0.154 | Src kinase inhibitor | 0.154 0.081 CID_135985157 | CID_135985157 | |
| 0.001 | 0.846 | 0.056 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.056 0.009 CID_121616 | CID_121616 | |
| 0.009 | 0.854 | 0.083 | Thioredoxin reductase inhibitor | 0.083 0.055 CID_121616 | CID_121616 | |
| 0.012 | 0.858 | 0.114 | D-Ala-D-Ala ligase inhibitor | 0.114 0.017 CID_121616 | CID_121616 | |
| 0.002 | 0.849 | 0.036 | Peptide deformylase inhibitor | 0.036 0.016 CID_121616 | CID_121616 | |
| 0.001 | 0.848 | 0.023 | Complement factor D inhibitor | 0.023 0.006 CID_121616 | CID_121616 | |
| 0.002 | 0.85 | 0.058 | Glutamate (mGluR3) antagonist | 0.058 0.009 CID_121616 | CID_121616 | |
| 0.001 | 0.85 | 0.06 | Oleamide hydrolase inhibitor | 0.06 0.02 CID_121616 | CID_121616 | |
| 0.007 | 0.856 | 0.081 | Nicotinic alpha3beta2 receptor antagonist | 0.081 0.012 CID_121616 | CID_121616 | |
| 0.03 | 0.879 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.057 CID_121616 | CID_121616 | |
| 0.004 | 0.853 | 0.113 | GABA B receptor agonist | 0.113 0.009 CID_121616 | CID_121616 | |
| 0.005 | 0.855 | 0.251 | Antiamyloidogenic | 0.251 0.071 CID_121616 | CID_121616 | |
| 0.007 | 0.856 | 0.13 | Thiol protease inhibitor | 0.13 0.096 CID_121616 | CID_121616 | |
| 0.003 | 0.855 | 0.061 | NMDA receptor agonist | 0.061 0.046 CID_121616 | CID_121616 | |
| 0.002 | 0.861 | 0.06 | Leukocyte elastase inhibitor | 0.06 0.018 CID_121616 | CID_121616 | |
| 0.012 | 0.872 | 0.269 | Neuropeptide Y2 antagonist | 0.269 0.04 CID_121616 | CID_121616 | |
| 0.001 | 0.863 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 CID_121616 | CID_121616 | |
| 0.003 | 0.865 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 CID_121616 | CID_121616 | |
| 0.002 | 0.865 | 0.074 | Biliverdin reductase inhibitor | 0.074 0.029 CID_135985157 0.071 0.032 CID_121616 | CID_135985157 | |
| 0.003 | 0.867 | 0.103 | GABA aminotransferase inhibitor | 0.103 0.025 CID_135985157 0.084 0.042 CID_121616 | CID_135985157 | |
| 0.002 | 0.866 | 0.1 | Argininosuccinate synthase inhibitor | 0.078 0.026 CID_135985157 0.1 0.019 CID_121616 | CID_121616 | |
| 0.003 | 0.87 | 0.214 | Calpain inhibitor | 0.214 0.101 CID_121616 | CID_121616 | |
| 0.013 | 0.882 | 0.145 | Hexokinase inhibitor | 0.145 0.085 CID_121616 | CID_121616 | |
| 0.007 | 0.877 | 0.144 | Electrolyte absorption antagonist | 0.108 0.047 CID_135985157 0.144 0.022 CID_121616 | CID_121616 | |
| 0.003 | 0.876 | 0.063 | Carbonic anhydrase VA inhibitor | 0.063 0.055 CID_121616 | CID_121616 | |
| 0.001 | 0.876 | 0.018 | CC chemokine 9 receptor antagonist | 0.018 0.009 CID_121616 | CID_121616 | |
| 0.004 | 0.879 | 0.075 | Vanilloid 3 antagonist | 0.075 0.004 CID_121616 | CID_121616 | |
| 0.002 | 0.878 | 0.049 | Nicotinic receptor alpha3 subunit antagonist | 0.049 0.025 CID_121616 | CID_121616 | |
| 0.009 | 0.886 | 0.224 | Peroxidase inhibitor | 0.224 0.053 CID_135985157 0.18 0.065 CID_121616 | CID_135985157 | |
| 0.004 | 0.881 | 0.064 | Cathepsin G inhibitor | 0.064 0.062 CID_121616 | CID_121616 | |
| 0.001 | 0.88 | 0.052 | Ornithine carbamoyltransferase inhibitor | 0.049 0.04 CID_135985157 0.052 0.037 CID_121616 | CID_121616 | |
| 0.001 | 0.88 | 0.032 | Protease (Human cytomegalovirus) inhibitor | 0.032 0.007 CID_121616 | CID_121616 | |
| 0.003 | 0.883 | 0.211 | CYP2A6 inhibitor | 0.066 0.065 CID_135985157 0.211 0.006 CID_121616 | CID_121616 | |
| 0.007 | 0.887 | 0.212 | Hypoxia-inducible factor 1 alpha inhibitor | 0.212 0.138 CID_121616 | CID_121616 | |
| 0.003 | 0.884 | 0.067 | Glutamate (mGluR group III) antagonist | 0.067 0.01 CID_121616 | CID_121616 | |
| 0.001 | 0.883 | 0.083 | Alcohol oxidase inhibitor | 0.082 0.023 CID_135985157 0.083 0.023 CID_121616 | CID_121616 | |
| 0.002 | 0.884 | 0.084 | Aconitate hydratase inhibitor | 0.084 0.012 CID_121616 | CID_121616 | |
| 0.002 | 0.885 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.054 CID_135985157 0.074 0.05 CID_121616 | CID_121616 | |
| 0.003 | 0.886 | 0.092 | GABA A receptor agonist | 0.092 0.045 CID_121616 | CID_121616 | |
| 0.004 | 0.888 | 0.104 | Microtubule formation inhibitor | 0.104 0.083 CID_121616 | CID_121616 | |
| 0.007 | 0.892 | 0.142 | TRPA1 agonist | 0.142 0.037 CID_121616 | CID_121616 | |
| 0.004 | 0.89 | 0.219 | Arachidonic acid antagonist | 0.219 0.018 CID_121616 | CID_121616 | |
| 0.003 | 0.892 | 0.246 | 12-Lipoxygenase inhibitor | 0.246 0.111 CID_121616 | CID_121616 | |
| 0.003 | 0.893 | 0.073 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.073 0.024 CID_121616 | CID_121616 | |
| 0.005 | 0.895 | 0.2 | 5 Hydroxytryptamine 1E antagonist | 0.2 0.13 CID_121616 | CID_121616 | |
| 0.003 | 0.894 | 0.054 | Retinoid X alpha receptor antagonist | 0.054 0.005 CID_121616 | CID_121616 | |
| 0.005 | 0.898 | 0.127 | DOPA decarboxylase inhibitor | 0.096 0.085 CID_135985157 0.127 0.037 CID_121616 | CID_121616 | |
| 0.005 | 0.898 | 0.238 | Thioredoxin glutathione reductase inhibitor | 0.238 0.143 CID_121616 | CID_121616 | |
| 0.007 | 0.901 | 0.154 | GABA C receptor rho-2 antagonist | 0.14 0.088 CID_135985157 0.154 0.068 CID_121616 | CID_121616 | |
| 0.004 | 0.897 | 0.225 | Insulin sensitizer | 0.225 0.051 CID_121616 | CID_121616 | |
| 0.004 | 0.9 | 0.063 | Glutamate (mGluR4) antagonist | 0.063 0.012 CID_121616 | CID_121616 | |
| 0.007 | 0.902 | 0.107 | Antibacterial (Helicobacter pylori) | 0.107 0.105 CID_121616 | CID_121616 | |
| 0.001 | 0.899 | 0.064 | Acyl-CoA dehydrogenase inhibitor | 0.064 0.03 CID_121616 | CID_121616 | |
| 0.003 | 0.901 | 0.142 | Pyruvate kinase inhibitor | 0.142 0.122 CID_121616 | CID_121616 | |
| 0.003 | 0.901 | 0.062 | Retinoid X receptor antagonist | 0.062 0.005 CID_121616 | CID_121616 | |
| 0.002 | 0.9 | 0.047 | Benzodiazepine antagonist | 0.047 0.034 CID_121616 | CID_121616 | |
| 0.006 | 0.905 | 0.204 | Aldehyde dehydrogenase inhibitor | 0.204 0.027 CID_121616 | CID_121616 | |
| 0.013 | 0.915 | 0.414 | GABA C receptor rho-3 antagonist | 0.38 0.071 CID_135985157 0.414 0.056 CID_121616 | CID_121616 | |
| 0.001 | 0.903 | 0.061 | Estradiol 17 beta-dehydrogenase inhibitor | 0.061 0.019 CID_121616 | CID_121616 | |
| 0.01 | 0.912 | 0.181 | Histone acetyltransferase inhibitor | 0.181 0.099 CID_121616 | CID_121616 | |
| 0.005 | 0.909 | 0.139 | Adenylate cyclase stimulant | 0.139 0.083 CID_121616 | CID_121616 | |
| 0 | 0.905 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | 0.014 0.007 CID_121616 | CID_121616 | |
| 0.006 | 0.91 | 0.112 | Glutamate dehydrogenase inhibitor | 0.112 0.025 CID_135985157 0.087 0.039 CID_121616 | CID_135985157 | |
| 0.004 | 0.909 | 0.249 | 15-Lipoxygenase inhibitor | 0.249 0.165 CID_121616 | CID_121616 | |
| 0.001 | 0.905 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | 0.042 0.036 CID_121616 | CID_121616 | |
| 0 | 0.906 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.018 CID_121616 | CID_121616 | |
| 0.001 | 0.906 | 0.054 | Retinoid X alpha receptor agonist | 0.054 0.013 CID_121616 | CID_121616 | |
| 0.005 | 0.912 | 0.074 | MAP kinase kinase 7 inhibitor | 0.074 0.067 CID_121616 | CID_121616 | |
| 0.003 | 0.909 | 0.199 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.199 0.101 CID_121616 | CID_121616 | |
| 0.004 | 0.911 | 0.218 | DNA polymerase beta inhibitor | 0.218 0.211 CID_121616 | CID_121616 | |
| 0.003 | 0.911 | 0.125 | Diuretic | 0.125 0.099 CID_121616 | CID_121616 | |
| 0.006 | 0.914 | 0.119 | Acetylcholine release stimulant | 0.119 0.05 CID_121616 | CID_121616 | |
| 0.004 | 0.914 | 0.055 | CD45 antagonist | 0.055 0.027 CID_121616 | CID_121616 | |
| 0 | 0.91 | 0.02 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.017 CID_121616 | CID_121616 | |
| 0.003 | 0.913 | 0.099 | Nitric-oxide synthase inhibitor | 0.099 0.062 CID_121616 | CID_121616 | |
| 0.003 | 0.914 | 0.134 | GABA receptor agonist | 0.134 0.045 CID_121616 | CID_121616 | |
| 0.005 | 0.917 | 0.616 | Aldehyde oxidase inhibitor | 0.616 0.017 CID_135985157 0.19 0.11 CID_121616 | CID_135985157 | |
| 0.006 | 0.918 | 0.144 | Vanilloid 1 agonist | 0.144 0.045 CID_121616 | CID_121616 | |
| 0.004 | 0.917 | 0.107 | Caspase 3 inhibitor | 0.107 0.08 CID_121616 | CID_121616 | |
| 0.004 | 0.917 | 0.098 | GABA C receptor rho-1 antagonist | 0.089 0.08 CID_135985157 0.098 0.065 CID_121616 | CID_121616 | |
| 0.005 | 0.919 | 0.28 | Transcription factor inhibitor | 0.28 0.166 CID_121616 | CID_121616 | |
| 0.003 | 0.917 | 0.169 | GABA C receptor agonist | 0.167 0.028 CID_135985157 0.169 0.028 CID_121616 | CID_121616 | |
| 0.001 | 0.915 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.014 CID_121616 | CID_121616 | |
| 0.004 | 0.921 | 0.22 | Succinate dehydrogenase inhibitor | 0.183 0.065 CID_135985157 0.22 0.035 CID_121616 | CID_121616 | |
| 0.001 | 0.918 | 0.066 | GABA uptake inhibitor | 0.066 0.008 CID_121616 | CID_121616 | |
| 0.004 | 0.923 | 0.103 | Carbonic anhydrase XV inhibitor | 0.103 0.063 CID_121616 | CID_121616 | |
| 0.001 | 0.92 | 0.156 | Porphobilinogen synthase inhibitor | 0.156 0.019 CID_135985157 0.14 0.023 CID_121616 | CID_135985157 | |
| 0.005 | 0.924 | 0.157 | Granulocyte macrophage colony stimulating factor agonist | 0.107 0.027 CID_135985157 0.157 0.005 CID_121616 | CID_121616 | |
| 0.004 | 0.926 | 0.371 | Transcription factor NF kappa B inhibitor | 0.371 0.071 CID_121616 | CID_121616 | |
| 0.008 | 0.93 | 0.156 | Phospholipase C inhibitor | 0.154 0.098 CID_135985157 0.156 0.094 CID_121616 | CID_121616 | |
| 0.005 | 0.931 | 0.142 | Sphingosine 1-phosphate receptor 4 antagonist | 0.142 0.041 CID_121616 | CID_121616 | |
| 0.002 | 0.928 | 0.072 | Aminopeptidase I inhibitor | 0.072 0.051 CID_121616 | CID_121616 | |
| 0.002 | 0.929 | 0.082 | Potassium channel (ATP-sensitive) blocker | 0.082 0.026 CID_121616 | CID_121616 | |
| 0.003 | 0.931 | 0.173 | Heat shock protein 90 alpha antagonist | 0.173 0.067 CID_121616 | CID_121616 | |
| 0.004 | 0.934 | 0.249 | Thyroid hormone beta antagonist | 0.249 0.119 CID_121616 | CID_121616 | |
| 0.001 | 0.937 | 0.106 | Histidine decarboxylase inhibitor | 0.106 0.03 CID_135985157 | CID_135985157 | |
| 0.002 | 0.94 | 0.079 | Histamine H2 receptor antagonist | 0.079 0.068 CID_121616 | CID_121616 | |
| 0.004 | 0.942 | 0.255 | Thyroid hormone antagonist | 0.255 0.121 CID_121616 | CID_121616 | |
| 0.003 | 0.941 | 0.066 | Carbonic anhydrase XIII inhibitor | 0.066 0.063 CID_121616 | CID_121616 | |
| 0.003 | 0.941 | 0.09 | Histamine N-methyltransferase inhibitor | 0.09 0.056 CID_121616 | CID_121616 | |
| 0.005 | 0.943 | 0.083 | Aminopeptidase B inhibitor | 0.083 0.079 CID_121616 | CID_121616 | |
| 0.003 | 0.943 | 0.131 | Heat shock protein 90 antagonist | 0.131 0.097 CID_121616 | CID_121616 | |
| 0.005 | 0.949 | 0.273 | Insulysin inhibitor | 0.273 0.077 CID_121616 | CID_121616 | |
| 0.004 | 0.948 | 0.353 | Transcription factor STAT inhibitor | 0.353 0.033 CID_121616 | CID_121616 | |
| 0.003 | 0.952 | 0.35 | Transcription factor STAT3 inhibitor | 0.35 0.033 CID_121616 | CID_121616 | |
| 0.003 | 0.954 | 0.053 | Immunoglobulin Fc receptor antagonist | 0.053 0.047 CID_121616 | CID_121616 | |
| 0 | 0.952 | 0.072 | Sirtuin 2 inhibitor | 0.072 0.007 CID_121616 | CID_121616 | |
| 0 | 0.967 | 0.039 | Geranyltranstransferase inhibitor | 0.039 0.038 CID_121616 | CID_121616 | |
| 0.002 | 0.973 | 0.145 | Neurotensin receptor agonist | 0.145 0.115 CID_121616 | CID_121616 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |